<?xml version="1.0" encoding="UTF-8"?>
<p id="Par17">Epidemiological studies outlined in Fig. 
 <xref rid="Fig2" ref-type="fig">2</xref> have pointed to several genes involved in mitochondrial function and recycling (e.g., 
 <italic>CHCHD2, PRKN, PLA2G6, VSP13C, PINK1, LRRK2</italic>; see also Table 
 <xref rid="Tab1" ref-type="table">1</xref>). An increase in dysfunctional mitochondria was identified in 26 independent hiPSC-PD studies using 
 <italic>LRRK2</italic>, 
 <italic>PRKN</italic>, 
 <italic>PINK1</italic>, 
 <italic>GBA</italic>, and 
 <italic>SNCA</italic> patient-derived neuronal lines
 <sup>
  <xref ref-type="bibr" rid="CR24">24</xref>,
  <xref ref-type="bibr" rid="CR27">27</xref>,
  <xref ref-type="bibr" rid="CR31">31</xref>,
  <xref ref-type="bibr" rid="CR32">32</xref>,
  <xref ref-type="bibr" rid="CR37">37</xref>â€“
  <xref ref-type="bibr" rid="CR39">39</xref>,
  <xref ref-type="bibr" rid="CR52">52</xref>,
  <xref ref-type="bibr" rid="CR55">55</xref>,
  <xref ref-type="bibr" rid="CR57">57</xref>,
  <xref ref-type="bibr" rid="CR59">59</xref>,
  <xref ref-type="bibr" rid="CR61">61</xref>,
  <xref ref-type="bibr" rid="CR62">62</xref>,
  <xref ref-type="bibr" rid="CR64">64</xref>,
  <xref ref-type="bibr" rid="CR67">67</xref>,
  <xref ref-type="bibr" rid="CR68">68</xref>,
  <xref ref-type="bibr" rid="CR70">70</xref>,
  <xref ref-type="bibr" rid="CR71">71</xref>,
  <xref ref-type="bibr" rid="CR73">73</xref>,
  <xref ref-type="bibr" rid="CR74">74</xref>,
  <xref ref-type="bibr" rid="CR77">77</xref>,
  <xref ref-type="bibr" rid="CR85">85</xref>,
  <xref ref-type="bibr" rid="CR89">89</xref>,
  <xref ref-type="bibr" rid="CR90">90</xref>
 </sup>. Neurons derived from PD patients displayed an increase in mitochondrial copy number
 <sup>
  <xref ref-type="bibr" rid="CR62">62</xref>
 </sup> and a greater proportion of abnormal mitochondria
 <sup>
  <xref ref-type="bibr" rid="CR31">31</xref>,
  <xref ref-type="bibr" rid="CR39">39</xref>
 </sup>. Abnormal mitochondria exhibited either signs of enlargement
 <sup>
  <xref ref-type="bibr" rid="CR31">31</xref>,
  <xref ref-type="bibr" rid="CR71">71</xref>
 </sup>, shortening
 <sup>
  <xref ref-type="bibr" rid="CR32">32</xref>
 </sup>, thinning
 <sup>
  <xref ref-type="bibr" rid="CR64">64</xref>
 </sup>, irregular cristae structures and network
 <sup>
  <xref ref-type="bibr" rid="CR59">59</xref>,
  <xref ref-type="bibr" rid="CR74">74</xref>
 </sup>, or fragmentation
 <sup>
  <xref ref-type="bibr" rid="CR24">24</xref>,
  <xref ref-type="bibr" rid="CR70">70</xref>
 </sup>. Mitochondria in the proximal axon of neurons from individuals carrying the 
 <italic>LRRK2 R1441C</italic> mutation were 20% shorter than individuals with 
 <italic>LRRK2-G2019S</italic> mutations
 <sup>
  <xref ref-type="bibr" rid="CR32">32</xref>
 </sup>. An increase in bidirectional mobility of mitochondria was also reported in 
 <italic>LRRK2</italic> lines but not in 
 <italic>PINK1</italic>
 <sup>
  <xref ref-type="bibr" rid="CR32">32</xref>
 </sup>. Overall, cellular respiration and metabolism were altered in neuronal lines derived from 
 <italic>LRRK2</italic>, 
 <italic>PRKN</italic>, 
 <italic>SNCA, PINK1</italic>, 
 <italic>DJ-1, and GBA</italic> patients
 <sup>
  <xref ref-type="bibr" rid="CR27">27</xref>,
  <xref ref-type="bibr" rid="CR37">37</xref>,
  <xref ref-type="bibr" rid="CR55">55</xref>,
  <xref ref-type="bibr" rid="CR58">58</xref>,
  <xref ref-type="bibr" rid="CR59">59</xref>,
  <xref ref-type="bibr" rid="CR61">61</xref>,
  <xref ref-type="bibr" rid="CR67">67</xref>,
  <xref ref-type="bibr" rid="CR70">70</xref>,
  <xref ref-type="bibr" rid="CR73">73</xref>,
  <xref ref-type="bibr" rid="CR83">83</xref>,
  <xref ref-type="bibr" rid="CR85">85</xref>
 </sup>. Basal mitochondrial respiration is consistently compromised across PD lines, exhibited as reductions in maximal oxygen consumption rate, diminished ADP and ATP levels and NAD+/NADH redox states
 <sup>
  <xref ref-type="bibr" rid="CR27">27</xref>,
  <xref ref-type="bibr" rid="CR55">55</xref>,
  <xref ref-type="bibr" rid="CR58">58</xref>,
  <xref ref-type="bibr" rid="CR59">59</xref>,
  <xref ref-type="bibr" rid="CR61">61</xref>,
  <xref ref-type="bibr" rid="CR67">67</xref>,
  <xref ref-type="bibr" rid="CR73">73</xref>,
  <xref ref-type="bibr" rid="CR85">85</xref>
 </sup>. Impaired mitochondrial respiration was also associated with an increase in mitochondrial ROS and lysosomal hyperactivity
 <sup>
  <xref ref-type="bibr" rid="CR67">67</xref>
 </sup>. The glycolytic rate of patient-derived neurons was higher in 
 <italic>PINK1</italic>
 <sup>
  <xref ref-type="bibr" rid="CR70">70</xref>
 </sup> and 
 <italic>PRKN</italic> lines
 <sup>
  <xref ref-type="bibr" rid="CR77">77</xref>
 </sup>. This was not observed in the transcriptomic analysis of 
 <italic>SNCA</italic> lines
 <sup>
  <xref ref-type="bibr" rid="CR90">90</xref>
 </sup>. An increase of passive proton leakage from the inner membrane was reported in 
 <italic>PINK1</italic> mutant neurons but not in 
 <italic>LRRK2</italic>
 <sup>
  <xref ref-type="bibr" rid="CR32">32</xref>
 </sup>. In addition, the degradation and translocation of mitochondrial membrane proteins such as PARKIN and MIRO1 were impaired in 
 <italic>LRRK2</italic> and 
 <italic>PRKN</italic> neurons
 <sup>
  <xref ref-type="bibr" rid="CR38">38</xref>,
  <xref ref-type="bibr" rid="CR62">62</xref>,
  <xref ref-type="bibr" rid="CR73">73</xref>
 </sup>.
</p>
